Related Experiment Video
Updated: Apr 30, 2026
Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization
Published on: June 7, 2016
Heterogeneity of microRNAs expression in cervical cancer cells: over-expression of miR-196a
Vanessa Villegas-Ruiz1, Sergio Juárez-Méndez2, Oscar A Pérez-González2
1Laboratorio de Oncología Genómica, UIMEO, Hospital de Oncología CMN-SXXI, IMSS, Mexico.
Abstract:
In recent years, the study of microRNAs associated with neoplastic processes has increased. Patterns of microRNA expression in different cell lines and different kinds of tumors have been identified; however, little is known about the alterations in regulatory pathways and genes involved in aberrant set of microRNAs. The identification of these altered microRNAs in several cervical cancer cells and potentially deregulated pathways involved constitute the principal goals of the present study. In the present work, the expression profiles of cellular microRNAs in Cervical Cancer tissues and cell lines were explored using microRNA microarray, Affymetrix. The most over-expressed was miR-196a, which was evaluated by real time PCR, and HOXC8 protein as potential target by immunohistochemistry assay. One hundred and twenty three human microRNAs differentially expressed in the cell tumor, 64 (52%) over-expressed and 59 (48%) under-expressed were observed. Among the microRNAs over-expressed, we focused on miR-196a; at present this microRNA is poorly studied in CC. The expression of this microRNA was evaluated by qRT-PCR, and HOXC8 by immunohistochemistry assay. There is not a specific microRNA expression profile in the CC cells, neither a microRNA related to HPV presence. Furthermore, the miR-196a was over-expressed, while an absence of HOXC8 expression was observed. We suggest that miR-196a could be played as oncomiR in CC.
Insights
Researchers identified miR-196a as a significantly over-expressed microRNA in cervical cancer (CC) cells. This finding suggests miR-196a may function as an oncomiR, potentially driving cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNA (miRNA) expression is increasingly linked to neoplastic processes.
- Aberrant miRNA regulatory pathways and genes in cervical cancer (CC) remain poorly understood.
- Identifying specific miRNAs and their roles in CC is crucial for understanding disease mechanisms.
Purpose of the Study:
- To identify differentially expressed microRNAs in cervical cancer tissues and cell lines.
- To investigate the role of over-expressed miR-196a and its potential target, HOXC8, in CC.
- To explore potential regulatory pathways affected by aberrant miRNA expression in CC.
Main Methods:
- MicroRNA microarray analysis (Affymetrix) was used to profile miRNA expression in CC tissues and cell lines.
- Quantitative real-time PCR (qRT-PCR) was employed to validate the expression of specific miRNAs, including miR-196a.
- Immunohistochemistry assays were performed to assess the expression of potential target proteins, such as HOXC8.
Main Results:
- A total of 123 differentially expressed miRNAs were identified in CC, with 64 (52%) over-expressed and 59 (48%) under-expressed.
- miR-196a was found to be significantly over-expressed in CC cells.
- Absence of HOXC8 protein expression was observed concurrently with miR-196a over-expression.
- No specific miRNA expression profile linked to HPV presence was identified in CC cells.
Conclusions:
- miR-196a is frequently over-expressed in cervical cancer.
- The inverse correlation between miR-196a and HOXC8 suggests a potential regulatory relationship.
- miR-196a is proposed to function as an oncomiR in the development of cervical cancer.
Related Concept Videos
01:22MicroRNAs
01:22MicroRNAs
01:22MicroRNAs
01:06Induced Pluripotent Stem Cells
Somatic...